Cargando…
Successful treatment with thalidomide for pemphigus vulgaris
BACKGROUND: Pemphigus vulgaris (PV) is a potentially life-threatening mucocutaneous autoimmune blistering disease characterized by suprabasal acantholysis, causing painful mucocutaneous blisters and erosions. Current mainstay therapy for pemphigus is systemic corticosteroids in combination with or w...
Autores principales: | Zhang, Bingjie, Mao, Xuming, Zhao, Wenling, Jin, Hongzhong, Li, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218931/ https://www.ncbi.nlm.nih.gov/pubmed/32426100 http://dx.doi.org/10.1177/2040622320916023 |
Ejemplares similares
-
Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023) -
Refractory pemphigus vulgaris successfully treated with ofatumumab
por: Klufas, Daniel M., et al.
Publicado: (2020) -
Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011) -
Successful Management of Severe Recalcitrant Pemphigus Vulgaris with Lenalidomide
por: Jain, Akshay Kumar, et al.
Publicado: (2022) -
Successful Treatment of Pemphigus Vulgaris With the Extensive Mucocutaneous Lesions in an Elderly Patient
por: Masjedi, Mohsen, et al.
Publicado: (2014)